Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature
Abstract The current study evaluated retinal function using electroretinography (ERG) in cognitively healthy (CH) participants with preclinical Alzheimer’s disease (AD), as classified by cerebral spinal fluid (CSF) Aβ42/Tau ratio. Individuals with normal retinal morphology ascertained by spectral-do...
Guardado en:
Autores principales: | Samuel Asanad, Christian M. Felix, Michele Fantini, Michael G. Harrington, Alfredo A. Sadun, Rustum Karanjia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f87f70fe13e448fc88e26ae7471dfe78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pannexin 1 sustains the electrophysiological responsiveness of retinal ganglion cells
por: Galina Dvoriantchikova, et al.
Publicado: (2018) -
Electrophysiological Biomarkers of Epileptogenicity in Alzheimer’s Disease
por: Tingting Yu, et al.
Publicado: (2021) -
PERG adaptation for detection of retinal ganglion cell dysfunction in glaucoma: a pilot diagnostic accuracy study
por: T. Salgarello, et al.
Publicado: (2021) -
Retinal ganglion cells are resistant to photoreceptor loss in retinal degeneration.
por: Bin Lin, et al.
Publicado: (2013) -
Hypoxia-ischemia and retinal ganglion cell damage
por: Charanjit Kaur, et al.
Publicado: (2008)